- Home
- Equipment
- netherlands
- harvesting
Show results for
Refine by
Harvesting Equipment Supplied In Netherlands
7 equipment items found
Manufactured by:Humeca based inBorne the, NETHERLANDS
The D42, a very maneuverable instrument, is an excellent tool in pediatric and general plastic surgery, especially for primary excision and harvesting grafts from curved surfaces. It also facilitates to harvest the 42×42 mm (1.65×1.65″) grafts required for Humeca’s MEEK technique, speeding up the procedure. The larger D80 dermatome was ...
Manufactured by:Humeca based inBorne the, NETHERLANDS
In co-operation with the Dutch surgeon Dr. Willem Nugteren, Humeca developed a dermatome for freehanded harvesting of a 30 mm (1¼ in.) wide split skin graft with a pre-determined thickness of about 0.25 mm (0.001 in.). This one-of-a-kind product is called the Sober dermatome. The shape of the Sober dermatome was derived from a safety razor. ...
Manufactured by:Humeca based inBorne the, NETHERLANDS
By expanding the Humeca product portfolio with these devices, we can now offer products that cover manual free handed harvest of (split-thickness) skin grafts and debridement of wounds, retaining our one-stop shop image for burn surgeons. These iconic devices are used in many hospitals around the world to treat burn patients. Although the devices might be common and familiar, ...
Manufactured by:Transportbandenfabriek EA Broekema BV based inVeendam, NETHERLANDS
We offer a wide range of support rollers suited for any kind of conveyor application. Please ask, if you are looking for a roller notincluded here. A roller’s surface may be plain base material like nylon, urethane or cast metal. It can also be lined with rubber. An axle’s shoulder length can be specified to position the roller under the rods or to compensate for distance variation ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease targets, where small molecules or antibody-based drugs cannot be used. However, the number of therapeutic peptide drugs is held back by properties that are inherent to wild-type peptides. Namely, that ...
by:XELTIS BV based inEindhoven, NETHERLANDS
The world’s first polymer-based technology platform designed to enable cardiovascular restoration – through ETR ...
by:XELTIS BV based inEindhoven, NETHERLANDS
Endogenous Tissue Restoration (ETR) is a new therapeutic approach, enabling the patient’s own body to naturally restore a new blood vessel or heart valve. With ETR, the patient’s natural healing system develops tissue that pervades Xeltis’ device, forming a new, natural and fully functional blood vessel or heart valve within it. As ETR occurs, Xeltis implants are gradually ...